Retractable Technologies, Inc. (NYSE:RVP – Get Free Report) CEO Thomas J. Shaw purchased 29,112 shares of Retractable Technologies stock in a transaction that occurred on Wednesday, January 22nd. The shares were purchased at an average cost of $0.78 per share, with a total value of $22,707.36. Following the transaction, the chief executive officer now directly owns 15,006,863 shares of the company’s stock, valued at $11,705,353.14. This represents a 0.19 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link.
Retractable Technologies Stock Up 7.7 %
NYSE RVP opened at $0.85 on Friday. Retractable Technologies, Inc. has a one year low of $0.56 and a one year high of $1.34. The stock has a 50-day moving average of $0.68 and a 200 day moving average of $0.83. The company has a current ratio of 8.57, a quick ratio of 5.92 and a debt-to-equity ratio of 0.01.
Analysts Set New Price Targets
Separately, StockNews.com started coverage on Retractable Technologies in a research note on Wednesday. They set a “hold” rating on the stock.
Institutional Trading of Retractable Technologies
An institutional investor recently bought a new position in Retractable Technologies stock. PFG Investments LLC bought a new position in Retractable Technologies, Inc. (NYSE:RVP – Free Report) in the third quarter, according to the company in its most recent disclosure with the SEC. The fund bought 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned 0.12% of Retractable Technologies at the end of the most recent quarter. 7.58% of the stock is currently owned by institutional investors.
Retractable Technologies Company Profile
Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.
Featured Articles
- Five stocks we like better than Retractable Technologies
- What is the Australian Securities Exchange (ASX)
- Why Energy Transfer Stock Could Soar to New Highs in 2025
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- 3 Buy-and-Hold Stocks for Long-Term Growth
- The Role Economic Reports Play in a Successful Investment Strategy
- Despite Short-Term Risks Freeport McMoran Worth a Look
Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.